Involvement of 5HT3 Receptors in Anti-Inflammatory Effects of Tropisetron on Experimental TNBS-Induced Colitis in Rat
Open Access
- 18 June 2013
- journal article
- Vol. 3 (4) , 169-176
Abstract
Introduction: There is a pressing need for research leading to the development of new effective drugs with lower side effects and more efficacy for treating inflammatory bowel disease (IBD). The analgesic and anti-inflammatory properties of 5-Hydroxytryptamine (5-HT)-3 receptor antagonists have been shown in in vivo and in vitro studies. The present study was designed to investigate the effects of tropisetron, a 5-HT3 receptor antagonist, on an immune-based animal model of IBD. Methods: In the present study, the trinitrobenzenesulfonic acid (TNBS) model of colitis in the rat was used. Two hours after induction of colitis in rats, tropisetron (2 mg/kg), dexamethasone (1 mg/kg), meta-chlorophenylbiguanide (mCPBG, 5 mg/kg), a 5-HT3 receptor agonist, or tropisetron + mCPBG were intraperitoneally (i.p.) administrated for 6 days. Animals were then sacrificed; macroscopic, histological, biochemical (myeloperoxidase [MPO]) assessments and ELISA test (tumor necrosis factor-alpha, interleukin-6 and interleukin-1 beta) were performed on distal colon samples. Results: Tropisetron or dexamethasone treatment significantly reduced macroscopic and microscopic colonic damages. In addition, a significant reduction in MPO activity and colonic levels of inflammatory cytokines was seen. The beneficial effects of tropisetron were antagonized by concurrent administration of mCPBG. Conclusion: The present study indicates that the protective effects of tropisetron on TNBS-induced colitis can be mediated by 5-HT3 receptors.Keywords
This publication has 39 references indexed in Scilit:
- Granisetron ameliorates acetic acid-induced colitis in ratsHuman & Experimental Toxicology, 2010
- 5-HT3 receptor antagonist for the treatment of tendinopathyNature Clinical Practice Rheumatology, 2008
- The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid‐induced colitis in ratsBritish Journal of Pharmacology, 2007
- Nicotine and serotonin in immune regulation and inflammatory processes: a perspectiveJournal of Leukocyte Biology, 2006
- Type 1 and 2 T helper cell-mediated colitisCurrent Opinion in Gastroenterology, 2006
- Review article: complementary and alternative therapies for inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2006
- Attenuation of acute experimental colitis by preventing NPY Y1 receptor signalingAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Review article: serotonin receptors and transporters — roles in normal and abnormal gastrointestinal motilityAlimentary Pharmacology & Therapeutics, 2004
- Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome 1 ☆Gastroenterology, 2004
- Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme MarkerJournal of Investigative Dermatology, 1982